Pfizer-BioNTech COVID-19 Vaccine, Bivalent has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals aged 6 months of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheets at www.cvdvaccine-us.com.
Monovalent mRNA COVID-19 vaccines are no longer authorized for emergency use in the United States. FDA and CDC guidance is to check inventory and dispose of monovalent mRNA vaccines according to state and local regulations.
Welcome to Pfizer-BioNTech COVID-19 Vaccines Medical Data
-
No cost, No sign-up required
-
Updated with peer-reviewed literature on COVID-19
-
Focus on the Pfizer-BioNTech COVID-19 Vaccine
-
Interactive
-
Key Point summaries to help understand medical data
This site is intended for US Healthcare Professionals. By selecting continue below, you acknowledge and certify that you are a US Healthcare Professional.
Emergency uses of the Pfizer-BioNTech COVID-19 Vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months of age and older. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.